Codagenix
PrivateLast Round
Grant
Oct 24, 2023
Total Funding Raised
$65.18M
Company Overview
Codagenix is a biotechnology company that develops live-attenuated viral vaccines and therapeutics using a synthetic biology platform.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials
Business Model
B2G
Customer Profile
Government Contracts, Services & Consulting
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Codagenix Comparables
Compare Codagenix with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| CyanVac LLC | 91% | |
| Blue Lake Biotechnology, Inc. | 88% | |
| Vivaldi Biosciences, Inc. | 83% | |
Codagenix Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Grant | Oct 24, 2023 | ||||
| Series B Extension | Feb 15, 2023 | ||||
| Grant | Aug 17, 2022 | ||||
| Grant | Jul 22, 2020 | ||||
| Series B | Jan 14, 2020 | ||||
VC Round | Oct 12, 2017 |
Key People
Founding team and executive leadership
Codagenix Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| National Institute of Allergy and Infectious Diseases | Grant |
| U.S. Department of Health and Human Services | Grant |
| United States Department of Defense | Grant |
| US Army Medical Research and Development Command | Grant |
| Public Health Emergency Medical Countermeasures Enterprise | Grant |
| Topspin Fund | Series B, Series A |
| Biomedical Advanced Research and Development Authority | Grant |
Market signals
Structured signals derived from secondary market and firmographic data.
- Oct 24, 2023
Received $6M from U.S. Department of Health and Human Services.
- Feb 15, 2023
$25M round led by Euclidean Capital and Serum Institute of India.
Codagenix Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Codagenix's valuation, stock price, and market status.